Division of Neurodegenerative Disorders, St. Boniface Hospital Research, Winnipeg, Manitoba, Canada.
Department of Pharmacology and Therapeutics, Faculty of Health Sciences, College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Neuroepidemiology. 2018;51(1-2):71-81. doi: 10.1159/000490414. Epub 2018 Jul 3.
Dementia is a growing public health concern in Canada. This epidemic is linked to huge human and economic costs. The number of Manitobans (65+) with dementia in 2045 (47,021), representing 2.58% of the Manitoban population, will be 2.3 times that of the year 2015 (20,235). The number of cases of dementia in Manitoba grew by 20.7% from 2015 to 2025, 68.16% from 2015 to 2035 and at an alarming rate of 125% from 2015 to 2045. Importantly, the total economic burden of dementia in Manitoba is close to one billion USD and is expected to grow more than 28 billion USD during the year 2038. The focus of this review is to compare dementia rates and the financial burden of dementia in Manitoba with the rest of Canada and the world from 2012 to 2048.
痴呆症是加拿大日益严重的公共卫生问题。这种流行病与巨大的人力和经济成本有关。到 2045 年,马尼托巴省(65 岁以上)痴呆症患者(47,021 人)的数量将是 2015 年(20,235 人)的 2.3 倍,占马尼托巴省人口的 2.58%。曼尼托巴省的痴呆症病例数从 2015 年到 2025 年增长了 20.7%,从 2015 年到 2035 年增长了 68.16%,到 2045 年惊人地增长了 125%。重要的是,曼尼托巴省痴呆症的总经济负担接近 10 亿美元,预计到 2038 年将超过 280 亿美元。本综述的重点是比较 2012 年至 2048 年期间,曼尼托巴省与加拿大其他地区和世界其他地区的痴呆症发病率和痴呆症经济负担。